白质高信号体积增加与海马萎缩率的相关性:一项基于人群的老龄化研究
本研究基于Insight46队列(1946年英国出生队列子研究),对317名无神经系统疾病的参与者(平均基线年龄70.5岁)进行约2.5年间隔的[18F]florbetapir PET/MRI扫描,量化白质高信号体积变化率(WMHVR)和海马萎缩率(HAR)。线性回归显示,WMHVR每增加1 mL/y,HAR增加0.014 mL/y(95%CI 0.005-0.022,p=0.002),该关联独立于心血管危险因素、APOE-ε4状态和β-淀粉样蛋白负荷,且未通过神经轴索损伤标志物NfL介导。
要点
- 白质高信号体积变化率与海马萎缩率独立相关。
- 该关联不受心血管危险因素、APOE-ε4或Aβ负荷影响。
- 神经轴索损伤标志物NfL未介导此关联。
核心结论
- 在约70至73岁人群中,较高的白质高信号体积变化率与较高的海马萎缩率相关,且独立于心血管危险因素、APOE-ε4状态和Aβ负荷,未由神经轴索损伤标志物介导。
研究设计与样本
- 研究纳入Insight46子研究(1946年英国出生队列)中317名无神经系统疾病的参与者,48%为女性,100%为英国白人,平均基线年龄70.5岁(SD=0.6)。
- 参与者接受两次[18F]florbetapir PET/MRI扫描,间隔约2.5年;WMHVR从T2/FLAIR序列量化,HAR从T1序列量化。
- 采用线性回归检验WMHVR与HAR的关系,调整性别、年龄、总颅内体积(TIV),并分别调整心血管危险因素、APOE-ε4状态和β-淀粉样蛋白。
- 事后分析采用结构方程模型检验NfL是否介导WMHVR与HAR的关系。
主要发现
- 平均HAR为0.04 mL/y(SD=0.04)。
- WMHVR每增加1 mL/y,HAR增加0.014 mL/y(95%CI 0.005-0.022),调整TIV、年龄和性别后p=0.002。
- 额外调整其他变量后关联未显著减弱(≥0.012 mL/y,p≤0.005,所有模型)。
- 未发现通过NfL的间接效应(0.0004 mL/y,95%CI -0.0006至0.0012,p<0.1)。
关键数值与推荐
- WMHVR每增加1 mL/y对应HAR增加0.014 mL/y(95%CI 0.005-0.022),p=0.002。
- 调整心血管危险因素、APOE-ε4或Aβ后,关联效应量≥0.012 mL/y,p≤0.005。
- NfL间接效应为0.0004 mL/y(95%CI -0.0006至0.0012),p<0.1。
临床怎么用
- 在老年人群中,白质高信号体积的持续增加可作为海马萎缩的独立相关因素,提示监测白质健康可能有助于评估海马萎缩风险。
- 该关联独立于AD病理和心血管危险因素,提示除AD特异性病理外,白质退化也是海马萎缩的相关因素。
局限性
- 研究结果需在更多样化的队列和更长随访期中重复验证。
- 样本全部为英国白人,限制了一般化。
- 观察性设计不能确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Higher white matter hyperintensity volume (WMHV) is associated with hippocampal atrophy, cognitive decline, and dementia; however, it is unknown whether continually increasing WMHV is related to hippocampal atrophy. The aim of this study was to determine whether higher WMHV change rate (WMHVR) is related to higher hippocampal atrophy rate (HAR); this relationship is dependent on cardiovascular risk factors (CVRFs), Alzheimer disease (AD) pathology, and genetic risk; and this relationship is mediated by neuroaxonal degradation. METHODS: Participants from Insight46, a substudy of the 1946 British Birth Cohort, underwent combined [18F]florbetapir PET/MRI scans at University College London approximately 2.5 years apart. WMHVR was quantified from T2/fluid-attenuated inversion recovery and HAR from T1 sequences. Life-course blood pressure and CVRF data were measured at 6 and 3 time points, respectively. APOE genotype and neurofilament light chain (NfL) quantification were derived from blood samples. Participants with neurologic conditions were excluded from primary analyses. Linear regression was used to test the relationships between WMHVR and HAR, adjusting for sex, age, and total intracranial volume (TIV) and CVRF, APOE-ε4 status, and β-amyloid (Aβ) in separate models. Semipartial R2 was calculated from these models. In a post hoc analysis, structural equation modeling aimed to determine whether NfL mediated the relationship between WMHVR and HAR. RESULTS: A total of 317 individuals without neurologic conditions (48% female, 100% White British, mean baseline age [SD] = 70.5 [0.6] years) were included. The mean HAR was 0.04 [0.04] mL/y. Each 1 mL/y increase in WMHVR was associated with a 0.014 mL/y (95% CI 0.005-0.022) increase in HAR, adjusted for TIV, age, and sex (p = 0.002). Adjustment for additional variables did not meaningfully attenuate this association (≥0.012 mL/y, p ≤ 0.005, all models), and there was no indirect effect through NfL (0.0004 mL/y [95% CI -0.0006 to 0.0012], p < 0.1). DISCUSSION: Higher WMHVR was associated with HAR between approximately 70 and 73 years, independent of CVRF levels, APOE-ε4 status, and Aβ load, and not mediated by markers of neuroaxonal degradation. Although AD-specific pathology is typically considered the main cause of accelerated HAR, we demonstrated that HAR is also linked to deteriorating WM health. These results will need to be replicated in more diverse cohorts with longer follow-up periods to confirm the findings.
引用
- Brown TM, James SN, Nicholas JM, et al. Association of Increase in White Matter Hyperintensity Volume With Rate of Hippocampal Atrophy in a Population-Based Study of Aging. Neurology. 2025. PMID: 40829101. doi:10.1212/WNL.0000000000213975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。